Instructions to Authors
Please read carefully. Failure to conform to standards
outlined here will delay processing. Instructions to authors of Medicina® are in accordance with the “Uniform Requirements for
Manuscripts Submitted to Biomedical Journals”, published by the
International Committee of Medical Journal Editors (ICMJE)1. The
standards for the Editorial process are in accordance with the
Committee on Publication Ethics (COPE) guidelines in „A Code of
Conduct for Editors of Biomedical Journals“2.
Please Note: Beginning March 1, 2008 Medicina© is following new policies.
General information and scope.
Medicina© is the official journal of the Croatian Medical Association – Rijeka Branch
and was launched in 1964. Medicina© is a peer-reviewed journal which publishes
articles of general interest in all aspects of human biomedical sciences, including
Basic snd Clinical research, Public health care and organization, Medical history
presentations, Medical bioethics and Medical education.
The audience for Medicina© titles consists of clinicians, research scientists and a
range of professionals in the healthcare community. Authors should bear in mind the
multidisciplinary status of the readership when writing the article.
The journal publishes the following types of articles: Editorials, Original scientific
papers, Short communications (Notes), Preliminary communications, Reviews,
Professional papers, Case reports, Conference papers, Meeting abstracts, Letters to
the Editor, Book reviews and Appendixes.
All manuscripts submitted to Medicina© must be written in Croatian or in English
and are given equal consideration, irrespective of country of origin, as long as the
main criteria are met (i.e. the manuscript is written and prepared according to the
Medicina© Instructions to authors and the article fits into the scope of Medicina©).
Neither the journal, nor the publisher will assume any responsibility for statements in
the articles, which are the sole responsibility of the authors.
A manuscript containing original material will be considered for publication with the
- all named authors have agreed to its submission
- if neither the article nor any part of its essential substance, tables, or figures
- has been or will be published elsewhere before appearing in Medicina© (this
restriction does not apply to abstracts or press reports published in
connection with scientific meetings)
- it is not under consideration for publication by another journal
- any work in preparation, submitted, in press, or published that is potentially
overlapping either in the actual data presented or in the conceptual approach
is enclosed along with the original submission
- if the paper is accepted it will not subsequently be published in the same or
similar form in any language in any other media without the consent of the
Following the recommendations contained in the Uniform Requirements, Medicina© defines “author” as a person who has participated sufficiently in the work to take
public responsibility for portions of the content. All persons designated as authors
should qualify for authorship and all those who qualify should be listed.
Specifically, an author is a person who:
- has made substantial contributions to conception and design, or acquisition of
data, or analysis and interpretation of data
- has drafted the submitted article or revised it critically for important
- has provided final approval of the version to be published.
Any person who does not meet all three of the listed criteria does not qualify as an
author and should not be designated as an author.
Those persons who contribute to the submitted manuscript, without qualifying as
authors (such as a person who provided purely technical help, writing assistance, or
a department chair who provided only general support), should be listed (with their
written permission) in the Acknowledgments section, together with a description of
their individual contributions and institutional affiliations. Financial and material
support should be named in the Acknowledgments, and what they did should be
described (for further information please see the Acknowledgments section).
When authorship is attributed to a group, all authors must meet the listed criteria
and must be responsible for the quality, accuracy, and ethics of the work. All authors
must participate in determining the order of authorship, and each author must be
prepared to explain the order in which authors are listed in the submission. The
Editor may require authors to justify the assignment of authorship.
The author designated as the corresponding author is responsible for correspondence
and copyright ownership of the manuscript. The corresponding author warrants that
the article is original, that is not under consideration by any other journal, that has
not been previously published, and that the data in the manuscript has been
reviewed by all authors, who agree with the analysis of the data and the conclusions
reached in the manuscript.
The corresponding author is the guarantor, and must assume full responsibility for
the integrity of the submission as a whole, from inception to published article.
Medicina© will correspond with only one author on each submission. It is the
responsibility of the designated corresponding author to communicate with the
Licence to Publish. Medicina Author Agreement.
Once manuscript has been accepted for publication, the Editorial office will send the
Authorship Agreement Form to the corresponding author. A copy of the Authorship
Agreement can be found on the journal web site (available at
http://hrcak.srce.hr/medicina). Authors should download the agreement and
complete, sign, and fax it to the Editorial Office. By signing the Agreement, each
author agrees to his or her obligations and makes certain representations in
connection with the submission. Among other things, each author is asked to
- he or she has participated sufficiently in the research and analysis of data, as
well as the writing of the manuscript, to qualify as an “author” under
- no portion of the work or a related work has been published previously or is in
preparation for or under consideration for publication elsewhere, except as
outlined either on the title page of the manuscript or in the cover letter
accompanying the submission
- all actual and potential conflicts of interest have been disclosed
- all information provided to Medicina© in connection with the submission is
true and complete, and complies with Medicina’s policies.
By signing the Medicina© Author Agreement, as required, each author grants
Croatian Medical Association an exclusive license to publish, in return for which they
can re-use their papers in their future printed work. An author’s intellectual property
rights transfer to Medicina© only if a manuscript is accepted for publication. The
manuscripts may not be submitted elsewhere for printing or publication.
Scientific integrity and responding to allegations of possible
If misconduct by authors or reviewers is suspected, either pre- or post-publication,
Medicina© reserves the right to proceed according to the procedures described
below. Authors have a right to respond to such allegations and for investigations to
be carried out with appropriate speed and due diligence. If the response is
unsatisfactory, then an appropriate authority will be asked to investigate fully.
Medicina© will correct the record or archive as necessary.
Some examples of misconduct include falsification of data, plagiarism (both
plagiarism of others and self-plagiarism), improper designations of authorship,
duplicate publication, misappropriation of others’ research, failure to disclose
conflicts of interest, and failure to comply with applicable legislative or regulatory
requirements. Misconduct also includes failure to comply with any of Medicina’s
other ethical rules and policies not specifically enumerated here
If the Editor discovers or is presented evidence of such problems, he will first consult
with the Executive Editors for Medical Ethics and with them contact the appropriate
officials (employers, funders, regulatory authorities) at the institutions from which
the manuscript originated and the journal publishers (Croatian Medical Association),
referring to information from the Committee on Publication Ethics (COPE),
encouraging them to investigate. It is then left to these institutions to pursue the
The journal will publish ‘retractions’ if work is proven to be fraudulent, or ‘expressions of concern’ if the Editor has well-founded suspicions of misconduct. If
the Editor was not aware that the article has already been published, a notice of
duplicate publication will be published without the authors’ explanation or approval.
Conflict of interest.
Authors are responsible for scientific integrity as well as the professional, scientific
and financial independency of the conducted research. Thereafter, all authors have
to sign the Conflict of Interest Disclosure Form (http://hrcak.srce.hr/medicina) and
return it to the Editorial office.
Authors must state explicitly whether potential conflicts do or do not exist (e.g.
personal or financial relationships that could influence their actions) and any such
potential conflict of interest (including sources of funding) should be summarized in a
separate section of the published article. Peer reviewers must disclose any conflicts
of interest that could bias their opinions of the manuscript, and they should
disqualify themselves from reviewing specific manuscripts if they believe it
Examples of potential conflicts of interest include, but are not limited to,
employment, consultancies, stock ownership, honoraria, paid expert testimony,
patent applications/registrations, and grants or other funding. Such information will
be held in confidence while the paper is under review and will not influence the
Editorial decision, but if the article is accepted for publication, Medicina© will
determine what, if any, pertinent parts of an author’s conflicts of interest disclosures
will appear with the article.
Conflict of Interest Policy for Editors.
Original manuscripts authored or coauthored by the Editor-in-Chief or the Associate
editor are handled by members of the Editorial board, who make the ultimate
acceptance or rejection. The entire process is handled confidentially.
The Editor-in-Chief may, from time to time, refer a manuscript, whether or not he is
the author, to the Associate editor or members of the Editorial board to avoid a real
or reasonably perceived conflict of interest.
Authors should understand that if accepted for publication, copyright of the paper
shall be assigned to the Publisher. Croatian Medical Association – Rijeka Branch is
the owner of all copyright to any work published by Medicina©. The Publisher and its
licensees have the right to use, reproduce, transmit, derive works from, publish, and
distribute the contribution, in Medicina© or otherwise, in any form or medium. The
full text of articles published in this journal can be used free of charge for personal
and educational purposes while respecting authors' and publishers' copyrights. For
commercial purposes, the authors may not use or authorize the use of the
contribution in any language without the written consent of the Publisher. No
material published in the journal may be stored on microfilm or videocassette or in
electronic databases or reproduced photographically without the prior written
permission of the publisher. The articles published in this journal are protected by
copyright, which covers translation rights and the exclusive right to reproduce and
distribute all of the articles printed in the journal.
Guidelines for Clinical Trials.
Medicina© defines a clinical trial according to the ICMJE definition. A clinical trial is
any research project that prospectively assigns human subjects to intervention or
concurrent comparison or control groups to study the cause-and-effect relationship
between a medical intervention (eg. drugs, devices, surgical procedures) and a
Medicina© prefer to publish clinical trials that have been included in a clinical trials
registry that is accessible to the public at no charge, is electronically searchable, is
open to prospective registrants and is managed by a not-for-profit organization, such
as www.clinicaltrials.gov (sponsored by the United States National Library of
Medicine)4. After successful registration, authors will obtain a registration number
which should be included (with registration database) at the end of article Abstract.
In manuscripts that report data from randomized clinical trials, authors should follow
the flow diagram or checklist in Consolidated Standards of Reporting Trials
(CONSORT) format and provide all of the information required by the CONSORT
checklist. If necessary, information may be submitted in a separate document
accompanying the manuscript submission. The CONSORT information is available at
Ethical conduct of studies involving humans and animals.
For studies involving data relating to human or animal experimental investigations,
appropriate institutional review board approval is required and should be described
within the article. For those investigators who do not have formal Ethics Review
Committees, the principles outlined in the Declaration of Helsinki of 1975 should be
followed (available at www.WMA.net). For investigations involving human subjects,
authors should explain how informed consent was obtained from the participants
Patients’ rights to privacy. Patients have a right to privacy that should not be
infringed without informed consent. Identifying information, including patients’ names, initials, or hospital numbers, should not be published in written descriptions,
photographs, and pedigrees unless the information is essential for scientific purposes
and the patient (or parent or guardian) gives written informed consent for
publication. Authors should disclose to these patients whether any potential
identifiable material might be available via the Internet as well as in print after
publication. When informed consent has been obtained it should be indicated in the
Studies involving animals must be carried out according to the Guiding principles for
research involving animals and human beings3 .
The Editor reserves the right to seek further clarification regarding the conditions
under which the study was performed and to refuse publication where ethical
approval is lacking.
Medicina© GUIDELINES FOR MANUSCRIPT
Authors should have read the Medicina© policies while writing the manuscript.
Correct preparation of the manuscript by the author(s) will expedite the reviewing
and publication procedures. Croatian-speaking authors may consult instructions in
Croatian at http://hrcak.srce.hr/medicina.
Submission of manuscripts.
To submit a manuscript, please prepare your manuscript according to the
instructions set forth in detail. Articles are submitted by e-mail to the Editor-inchief:
Please name your manuscript in the following style: Surname – Manuscript
(example, Elliott – Manuscript).
Receipt of all manuscripts will be acknowledged within 1 week and authors will be
notified as to whether the article is to progress to external review. If an author does
not receive confirmation of submission, he or she should contact the Editorial Office.
Initial screening of articles by the Editor-in-Chief or members of the Editorial board
will assess the topicality and importance of the subject, the clarity of presentation,
and relevance to the audience of the journal.
If the submission is incomplete (eg. missing text components, figures, tables, etc.),
the corresponding author will be informed of what is missing and will be asked to
resubmit a complete version.
Although we prefer manuscripts to be submitted electronically, alternatively, the
original copy of the manuscript and all supporting material can be sent on a compact
disc (CD) to the Editorial Office of Medicina via regular mail to the following address:
Croatian Medical Association – Branch of Rijeka, Krešimirova 52a/V, p.p. 227, 51000
Rijeka, Croatia (HR).
When submitting a new manuscript, the authors must download and fill out the
Submission Form from our website http://hrcak.srce.hr/medicina. The Submission
Form includes the following information:
- General manuscript information (Title, Authors, Corresponding Author)
- Type of article that the manuscript represents
- Number of pages (excluding abstract, acknowledgments, figure legends, and
references). This allows the Editor and reviewers to assess whether the
information contained in the paper warrants the amount of space devoted to
it, and whether the submitted manuscript fits within the journal’s page limits
- The number of Figures and Tables
- Names and addresses of at least two reviewers
- A statement of financial or other relationships that might lead to a conflict of
interest, if that information is not included in the manuscript itself
- Statement that the manuscript has been read and approved by all the authors
- Copies of any permission to reproduce published material, to use illustrations
or report information about identifiable people, or to name people for their
contributions must accompany the manuscript
- Any additional information that may be helpful to the Editor
The manuscript should not exceed 20 A4 pages (standard margins 2.5cm)
without references, tables and figures. Editorial holds rights to all necessary
changes to language and style of the original manuscript needed to adhere
to uniform standards of the journal.
Manuscripts (including all text, references, figure legends, and tables) should be
typed, double spaced in Croatian or standard English, with 11-point Arial font
and each page numbered in the lower right corner starting with the title
page. Our preferred file type for new manuscript submissions is Word Doc documents. Each figure should be prepared as a separate digital file (see figure
preparation instructions that follow).
Order the elements comprising the manuscript as follows:
- Title page
- Key words
- Organizational components depending on the article type (Please be sure to
read which organizational components are required for each article type at
- Figure legends
Title page. This should include:
- The title of the article: in English and Croatian; 100 characters without spaces
max. The title should reflect the content of the article. Avoid declarative
statements, questions, titles that tantalize but do not inform readers, and
- Full names of each author with institutional affiliations (the name and address
of the institution(s) from which the work originated). Avoid any
abbreviations of academic or professional titles
- Reprints and correspondence: Please provide full name and complete
addresses, telephone and fax numbers of the corresponding author, to whom
communications, proofs and reprint requests should be sent to with contact
Abstract. Abstract should be written both in English and Croatian. It should consist
of no more than 250 words, and organized into paragraphs depending on the
article type (for example in original scientific article the paragraphs should be labeled
Aim, Methods, Results, Discussion and Conclusions). The abstract should provide the
context or background for the study and should state the study’s purposes, basic
procedures (selection of study subjects or laboratory animals, observational and
analytical methods), main findings (giving specific effect sizes and their statistical
significance), and principal conclusions. For all clinical trials (see Medicina© Policies), the trial registry name and registration number must be stated at the end
of the Abstract.
For full details on the organization of abstract depending on the article type, please
Key words. A list of 3-6 key words is to be provided directly below the abstract. Key
words should express the precise content of the manuscript and consist of words or
phrases not in the title, as they are used for indexing purposes. They should each be
arranged in alphabetical order and separated by a comma (,).
Acknowledgments. All contributors who do not meet the criteria for authorship
should be listed in an acknowledgments section. Corresponding authors should
declare whether or not they had assistance with study design, data collection, data
analysis, or manuscript preparation. If such assistance was available, the authors
should disclose the identity of the people that provided this assistance and the entity
that supported it in the published article. Grant, financial and material support
should also be acknowledged. All acknowledgments should be typed in one separate
paragraph that directly precedes the reference section. The inclusion of individuals
and/or of institutions in the acknowledgment section in a manuscript requires a
signed approval from each individual mentioned in the acknowledgment and/or of an
authorized individual representing the institution(s) that clearly states that the
individual(s) and/or institution(s) agree to be named in an acknowledgment section
of the paper. Illustrations from other publications must be acknowledged. The
corresponding author must sign the Acknowledgment Section of the Copyright
References. The Editorial department checks all references for validity, however,
authors are responsible for the accuracy of their references.
In text, tables and legends, references must be given as superscript Arabic
numerals, numbered consecutively in the order in which they appear in the text. At
the end of the papers they should be listed as full citations (double-spaced) in
numerical order corresponding to the order of citation in the text. References cited
only in tables or figure legends should be numbered in accordance with the sequence
established by the first identification in the text of the particular table or figure. Once
a reference is cited, all subsequent citations should be to the original number. If
more than two consecutive references are encountered, please separate them with a dash.
Abbreviations for titles of medical journals should conform to those used in the latest
edition of Index Medicus (please visit
ftp://nlmpubs.nlm.nih.gov/online/journals/ljiweb.pdf). Whenever possible, authors
should focus on recent papers. Papers of particular interest can be identified using
one asterisk symbol (*) and chosen references should be annotated with a brief
sentence explaining why the reference is considered to be of interest. If more than
two consecutive references are encountered, please separate them with a dash.
The following are sample references:
Standard Journal article. Santos F, Dean W. Epigenetic reprogramming during
early development in mammals. Reproduction 2004;127:643-51.
Six or more authors. Reik W, Constância M, Fowden A, Anderson N, Dean W,
Ferguson-Smith A et al. Regulation of supply and demand for maternal nutrients
in mammals by imprinted genes. J Physiol 2003;547:35-44.
Journal article with organization as author. Institute of Medical Illustrators.
Photography of cleft audit patients. J Audiov Media Med. 2004;27:170-4.
Journal article with governmental body as author. National Institutes of
Health (US). End-of-life care. National Institutes of Health statement on the state
of the science. AWHONN Lifelines. 2005;9:15-22.
Journal article within a supplement. Draghici S, Khatri P, Shah A, Tainsky
MA. Assessing the functional bias of commercial microarrays using the ontocompare
database. Biotechniques. 2003;(Suppl):55-61.
In press. Savinainen KJ, Helenius MA, Lehtonen HJ, Visakorpi T. Overexpression
of EIF3S3 promotes cancer cell growth. Prostate. In press 2006.
Internet resource. Organ Procurement and Transplantation Network. National
Data Reports. Available at http://www.optn.org/latestData/step2.asp. Accessed
January 7, 2008.
Standard book with initials for authors. Benirschke K, Kaufmann P, Baergen
RN. Pathology of the Human Placenta. 5th Edition. New York: Springer Science,
Volumes of Books with a Separate Title for the Volume but Without
Separate Authors/Editors: Moller TB, Reif E. Pocket atlas of sectional
anatomy: computer tomography and magnetic resonance imaging. Vol. 2,
Thorax, abdomen, and pelvis. Stuttgart: Thieme, 2001; 226.
Parts of books. Bhatia S, Robinson LL. Epidemiology of leukemia in childhood.
In: Nathan DG, Orkin SH, Look AT, Ginsburg D (eds). Nathan and Oski's
Hematology of Infancy and Childhood. Philadelphia: Saunders Company,
Dissertations and theses:
Banić D. Kvaliteta života bolesnika na redovitoj hemodijalizi. Rijeka: Medicinski
fakultet, 1997;85. PhD thesis.
Papers and Poster Sessions Presented at Meetings:
Standard paper presented. Bernhardt A, Weiss C, Breuer J, Kumpf M,
Sieverding L. The clinical relevance of an elevated lactate level after surgery for
congenital heart disease. Abstracts of the 3rd International Symposium on the
Pathophysiology of Cardiopulmonary Bypass. Aachen, 2000;16.
Standard poster presented. Chasman J, Kaplan RF. The effects of occupation
on preserved cognitive functioning in dementia. Poster session at 4th Annual
Conference of the American Academy of Clinical Neuropsychology. Philadelphia,
Journals on the internet:
Terauchi Y, Takamoto I, Kubota N. Glucokinase and IRS-2 are required for
compensatory beta cell hyperplasia in response to high-fat diet-induced insulin
resistance. J Clin Invest [Internet]. 2007;117:246-57. Available from:
Personal communications, unpublished observations, and submitted manuscripts are not legitimate references. They must be cited in the text only (not
in the reference list) as follows: author name, degree(s) held, unpublished data,
year. If authors wish to cite the unpublished observations of other workers they need
to make sure they hold all necessary permissions.
Tables. These should be labeled sequentially as Table 1, Table 2, etc and each
should have a short descriptive title. Each table should be self-explanatory, typed
double-spaced on separate page, and numbered consecutively with Arabic numerals.
Use superscript lowercase letters to denote footnotes within a table in the order they
appear. Each table must include definitions of all abbreviations that have been used.
Abbreviations must be used more than once; if not, do not abbreviate but write out.
Be sure that each table is cited in the text.
Tables should not duplicate the content of the text. Unlike figures or images, tables
may be embedded into the separate pages at the end of the manuscript, or supplied
as separate electronic files.
Figures and Illustrations. Figures and images should not be inserted or embedded
into the manuscript document; rather, they should be saved and uploaded as
separate files and numbered consecutively according to the order in which they have
been first cited in the text (i.e. Figure 1, Figure 2 etc).
Medical and scientific illustrations will be created or redrawn in-house if necessary. If
an outside illustrator has created a figure, Medicina© reserves the right to modify or
redraw it to meet our specifications for publication. The author must explicitly
acquire all rights to the illustration from the artist in order for us to publish it.
- Format of submitted art: Supported formats include TIFF, GIF, JPEG, PDF,
- Resolution: Files must conform to the following minimum resolution
specifications: 300 dpi for black and white and color photographs with no
labeling; 600 dpi for combination figures (photographs with labeling); 1200
dpi for line art (eg. graphs, drawings that have no gray tones). For x-ray
films, scans, and other diagnostic images, as well as pictures of pathology
specimens or photomicrographs, send sharp, glossy, black-and-white or color
photographic prints. It is permissible to send low-resolution images for peer
review, although we may ask for high-resolution files at a later stage.
- Image size: Images should be 20.0 cm wide by 14.5 cm high.
A reasonable number of colour illustrations will be reproduced free of cost to the
author, but special arrangements must be made with the Editor for extensive color
plates, elaborate tables, or extra illustrations.
When sending the manuscript by standard mail. All supporting material to the
manuscript can be sent on a compact disc (CD) to the Editorial Office. Illustrations
and photographs should not be included in the manuscript itself, but rather as a
separate file named according to the order they appear in the manuscript.
Illustrations will not be returned.
Legends for Figures and Illustrations. Figures should be labeled sequentially,
numbered and cited in the text. Figure legends should be printed and double-spaced
on a separate sheet entitled “Titles and legends to figures”, with Arabic numerals
corresponding to the illustrations. Figures should be made as self-explanatory as
possible. Titles and detailed explanations belong in the legends and not on the
illustrations themselves. Provide a short title in the legend. Maximum length of
legends should be limited to 200 words. Letters, numbers, and symbols on Figures
should be clear and even throughout, and of sufficient size that when reduced for
publication each item will still be legible.
When symbols, arrows, numbers, or letters are used to identify parts of the
illustrations, identify and explain each one clearly in the legend. Photomicrographs
should have internal scale markers, which have to be explained and the method of
staining in photomicrographs should be indetified. Symbols, arrows, or letters used
in photomicrographs should contrast with the background.
Highlights (summary). Highlights are intended to awake interest of the reader and
state the most important aspects of the article. The author should include a separate
Word doc file named „Surname - Highlights“ in which he or she will include a series
of bulleted statements which represent key problems and conclusions, unresolved
issues and points for emphasis of work in future (two paragraphs of maximum 50
words). After the manuscript is accepted for publication, these statements will
appear throughout text in separate tables, highlighting the most important issues of
Abbreviations and units of measurement.
Authors should express all measurements in Système International (SI) units given
in parentheses throughout the text. Except for units of measurement, abbreviations
should be used as few as possible. Abbreviations must be defined at first mention.
Use only standard abbreviations and avoid abbreviations in the title. The full term for
which an abbreviation stands should precede its first use in the text unless it is a
standard unit of measurement.
Drug names and Devices.
Generic names of drugs should be used. In the Methods, the complete name and
location of the manufacturer must be supplied for all reagents, equipment, and
Medicina© MANUSCRIPT PROCESSING
Upon receipt Manuscripts are evaluated by Editor-in-Chief or members of the
Editorial board. Those manuscripts that do not meet the main criteria stated in the
Instructions to authors will be returned to authors. The manuscripts are also
returned if they are either out of scope or below threshold for the journal, or the
presentation or written English is of an unacceptably low standard. Before sending
the manuscript to suggested reviewers, The Editor may have suggestions for the
improvement of data presentation. The author should closely follow the instructions,
revise the manuscript, and submit the revised version. Authors are advised to keep a
copy of all manuscripts submitted, because Medicina© will not return submitted
As Medicina© is a peer reviewed journal, all manuscripts must go through review
process. Review is performed on a double-blind basis – the identities of peer
reviewers and authors are kept confidential. Peer reviewers complete a referee
report form, to provide general comments to the editor and both general and specific
comments to the author(s).
Author(s) must submit the names and current e-mail addresses of two or more
possible reviewers which are qualified to review the subject area and haven’t seen
the manuscript before submission. We encourage authors to suggest the names of
possible reviewers, but suggested reviewers can be considered alongside potential
reviewers identified by their publication record or recommended by Editorial board
members. Each reviewer is informed of the deadline date for returning their
evaluation to the authors. If a reviewer does not return his or her manuscript
evaluation by the deadline date, then the Editor will either send a follow-up e-mail
requesting the review or will appoint a new reviewer. Once reviewed, manuscript
accompanied with reviewers’ remarks is sent back to the author. Decisions on
acceptance or rejection will be communicated only by email to the corresponding
author. Submitted material remains confidential.
After peer review is complete, a further week or two (depending on the Editor's
decidion) is allowed for any revisions to be made. In your written response to the
reviewers' comments, give the exact page number(s), paragraphs(s) and line
number(s) where each revision was made. The final decision on acceptability for
publication lies with the Editor.
All accepted manuscripts are subject to copyediting for conciseness, clarity,
grammar, spelling, and Medicina© style.
Acceptance is based on significance, originality, and validity of the material
presented. On acceptance of a manuscript, all authors must sign an Authorship
Agreement, Conflicts of Interest Disclosure Form and Copyright Transfer
Form. These Forms can be found at http://hrcak.srce.hr/medicina. Please complete,
sign, and fax the Forms to the Editorial Office. Failure to submit completed signature
Forms will delay publication. To ensure proper handling, it is suggested that the
corresponding author collects the completed Forms from each author and fax them,
simultaneously, to the Editorial Office.
After the revised manuscript has been accepted for publication, it will undergo
production in-house. This will involve type-setting, copy-editing, proof-reading and
re-drawing of any graphics. Authors will receive proofs of the article to approve
before going to print, and will be asked to sign a Copyright Transfer Form.
Appeals against rejection.
Where an author believes that the Editor has made an error in declining a paper,
they may submit an appeal. Authors should contact the Editor and the appeal letter
should clearly state the reasons why the author(s) considers the decision to be
incorrect and provide detailed, specific responses to any comments relating to the
rejection of the review.
The appeals which may succeed are only those in which the reviewers made factual
errors, or the importance of the findings was not understood. It is not productive to
appeal lack of scientific priority, or subjective Editorial considerations, such as
estimation of limited interest to our readership, inability to compete successfully for
space with other recently accepted papers, or Editorial necessity to achieve balance
among different types of submissions.
If the Editor decides to accept the appeal and reconsider the contribution for
publication, the Editorial Office will be informed. This is necessary because authors
are not authorised to act on their manuscripts after rejection and the Editorial Office
will have to enable them to either confirm the old version for reconsideration or
upload a new one. The Editor will assign the manuscript to new reviewers, or review
it himself, and subsequently take his decision. The Editor’s decision following the
appeal process is final.
Complaints against the Editor or the journal should be made directly to him or her in
writing. If the complaint is not resolved satisfactorily, it should be passed to the
Executive Editors for Medical Ethics and Editor’s overseeing body. Where a complaint
remains unresolved, the complainant can refer the matter to the Committee on
Publication Ethics (COPE).
Publishing corrections, apologies and retractions.
We encourage authors and readers to inform the Editorial office if they discover
errors in published work. Mistakes by either editor or author should be identified wherever possible and an erratum or corrigendum will be published at the earliest
- The Editor will publish corrections if errors are discovered that could affect the
interpretation of data or information presented in an article. Other
notifications should explain why the article is being retracted, or should
explain the Editor’s concerns about the contents of the article.
- Corrections will be included in indexing systems and linked to the original
article wherever possible.
- The title of the erratum, retraction, or apology will include the words “Erratum”, “Retraction”, or ‘Apology” and will be published on a numbered
page (print and electronic) and listed in the journal’s table of contents.
- If an honest error has been detected which was made from the side of the
journal, an apology to author will be published along with the correction if
The manuscript, when published, will become the property of the journal and
copyright will be taken out in the name of the Publisher, the Croatian Medical
Association – Rijeka Branch.
No part of materials published in Medicina© may be reproduced without written
permission. Written permission is required from both publisher and author if text
material more than 250 words verbatim, or any illustration, is borrowed from
published sources. A credit line should be included to identify the source. Permission
letters for reproduced text or illustration must accompany the manuscript.
Photographs of identifiable persons must be accompanied by signed releases
showing informed consent.
Address requests for permission to use material published in Medicina© for other
publications to: Croatian Medical Association – Rijeka Branch, Krešimirova 52a/V,
p.p. 227, 51000 Rijeka, Croatia (HR).
Permissions for Previously Published Illustrations, Tables or Text.
If previously published tables, illustrations or text are to be included, then this
should be clearly indicated in the manuscript and the copyright holder's (usually the
publisher) permission must be obtained. As the author of your manuscript, you are
responsible for obtaining permissions to use material owned by others. Please send
us photocopies of letters or forms granting you permission for the use of copyrighted
material so that we can see that any special requirements with regard to wording
and placement of credits are fulfilled. The original source should be cited in the figure
caption or table footnote.
Medicina© can consider the publication of an already published article, but in
another language if the authors have received approval from the Editors of both
journals, the paper for secondary publication is intended for a different group of
readers, and this is clearly stated on the title.
Until the necessary written permissions are received, a manuscript cannot be
published. Please fax the signed Permissions Form to the Editorial office (Attn:
Editorial Department, Permissions) or scan them and upload them with the
The Publisher and the Editor cannot be held responsible for errors or any
consequences arising from the use of information contained in Medicina©. The
statements and opinions contained in editorials and articles in this journal are solely
those of the authors and not of the Croatian Medical Association, or of its officers,
regents, members, and employees. The appearance of advertisements or services
advertised or of their effectiveness, quality, or safety are solely those of the
advertisers. The Editor-in-Chief, the Croatian Medical Association, its officers,
regents, members, and employees disclaim all responsibility for any injury to
persons or property resulting from any ideas or products referred to in articles or
advertisements contained in this Journal.
- International Committee of Medical Journal Editors. Uniform requirements for
manuscripts submitted to biomedical journals. Available at: www.icmje.org. Accessed
March 1, 2008
- Committee on Publication Ethics. A Code of Conduct for Editors of Biomedical
Journals. Available at: http://www.publicationethics.org.uk/guidelines. Accessed
March 1, 2008
- American Physiological Society; World Medical Association General Assembly.
Guiding principles for research involving animals and human beings. Am J Physiol
Cell Physiol 2002;282:3.
- Laine C, De Angelis C, Delamothe T, Drazen JM, Frizelle FA, Haug C et al. Clinical
trial registration: looking back and moving ahead. Ann Intern Med 2007;147:275-7.
Saša Ostojić, M.D., Ph.D.
Department of Biology and medical genetics
School of Medicine, University of Rijeka
Braće Branchetta 20, 51000 Rijeka
Croatian Medical Association – Rijeka Branch
Krešimirova 52a/V, p.p. 227, 51000 Rijeka